Meghan McKenzie is a Clinical Program Director in Genentech’s Research and Early Development (gRED). Meghan has worked across all phases of drug development for over 20 years. In Clinical operations, she manages complex programs in Neurology and Infectious Disease and is leading gRED’s Patient Centricity team. The gRED Patient Centricity vision is to empower Early Clinical Development to obtain and amplify the patient voice to improve development planning, trial design, and trial execution. This team also focused on Inclusion Research.
She received her Bachelor’s in Economics at UNC- Chapel Hill and her Master’s in Biology: Human Physiology at San Francisco State University. Before joining Genentech in 2005, Meghan held various positions at a CRO, a research site, at NASA in their Human Research Center as well as at nonprofit think tanks in Washington, D.C.
She and her husband (a veterinarian) have two dogs, and they enjoy music and travel with their 19-year old daughter, when they can get her attention.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948